An overview of FDA-approved vaccines & their innovators

References

• Whitney C, Zhou F, Singleton J, et al. Benefits from immunization during the vaccines for children program era–United States, 1994–2013. Morbidity Mortality Weekly Report. 2014;63(16):352–355.
   PubMed Web of Science ®Google Scholar
• Scannell JW, Blanckley A, Boldon H, et al. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012;11(3):191–200.
   PubMed Web of Science ®Google Scholar
• Adams DA, Jajosky RA, Ajani U, et al. Summary of notifiable diseases–United States, 2012. MMWR Morb Mortal Wkly Rep. 2014;61(53):1–121.
   PubMedGoogle Scholar
• Waldmann TA. Immunotherapy: past, present and future. Nat Med. 2003;9(3):269–277.
   PubMed Web of Science ®Google Scholar
• DeHovitz RE. The 1901 St Louis Incident: the first modern medical disaster. Pediatrics. 2014;133(6):964–965.
   PubMed Web of Science ®Google Scholar
• Dixon ME, Why nine Camden children died from smallpox vaccines in 1901. Main Line Today. 2016. [cited 2016 Nov 15]. http://www.mainlinetoday.com/Main-Line-Today/September-2016/Why-Nine-Camden-Children-Died-from-Smallpox-Vaccines-in-1901/
   Google Scholar
• Kinch MS. A prescription for change: the looming crisis in drug discovery. Chapel Hill (NC): UNC Press; 2016.
   Google Scholar
• Greeley AP. The food and drugs act, June 30, 1906: A study with text of the act, annotated, the rules and regulations for the enforcement of the act, food inspection, decisions and official food standards. J Byrne. 1907, p. 1–12.
   Google Scholar
• Kinch MS, Haynesworth A, Kinch SL, et al. An overview of FDA-approved new molecular entities: 1827–2013. Drug Discov Today. 2014;19:1033–1039.
   PubMed Web of Science ®Google Scholar
• Munos B. Lessons from 60 years of pharmaceutical innovation. Nat Rev Drug Discovery. 2009;8:959.
   PubMed Web of Science ®Google Scholar
• Kinch MS. The rise (and decline?) of biotechnology. Drug Discov Today. 2014;19:1686–1690.
   PubMedGoogle Scholar
• Kinch MS, Moore R. Innovator organizations in new drug development: assessing the sustainability of the biopharmaceutical industry. Cell Chem Biol. 2016;23(6):644–653.
   PubMed Web of Science ®Google Scholar
• Mbow ML, De Gregorio E, Valiante NM, et al. New adjuvants for human vaccines. Curr Opin Immunol. 2010;22(3):411–416.
   PubMed Web of Science ®Google Scholar
• Marrack P, McKee AS, Munks MW. Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol. 2009;9(4):287–293.
   PubMed Web of Science ®Google Scholar
• Hoyt K. Long shot: vaccines for national defense. Cambridge (MA): Harvard University Press; 2012.
   Google Scholar
• Tomes N. Remaking the American patient: how Madison Avenue and modern medicine turned patients into consumers. Chapel Hill, North Carolina: UNC Press Books; 2016.
   Google Scholar
• Wagner K, Stickings P, White J, et al. A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use. Vaccine. 2009;28(1):14–20.
   PubMed Web of Science ®Google Scholar
• Underwood EA. Edward Jenner, Benjamin Waterhouse, and the introduction of vaccination into the United States. Nature. 1949;163:823–828.
   Web of Science ®Google Scholar
• Riedel S. Edward Jenner and the history of smallpox and vaccination. Proc (Bayl Univ Med Cent). 2005;18(1):21–25.
   PubMedGoogle Scholar
• Starr D. Blood: an epic history of medicine and commerce. Knopf. 2012, p. 89–100.
   Google Scholar
• Hitt E. Poor sales trigger vaccine withdrawal. London, England: Nature Publishing Group; 2002.
   Google Scholar
• Morgan AJ, Parker S. Translational mini-review series on vaccines: the Edward Jenner Museum and the history of vaccination. Clin Exp Immunol. 2007;147(3):389–394.
   PubMed Web of Science ®Google Scholar
• Smith KA. Edward Jenner and the small pox vaccine. Front Immunol. 2011;2:21.
   PubMed Web of Science ®Google Scholar
• Kinch MS. An overview of FDA-approved biologics medicines. Drug Discov Today. 2015 Apr 30;20(4):393–398.
   Google Scholar
• Galambos L, Sewell JE. Networks of innovation: vaccine development at Merck, Sharp and Dohme, and Mulford, 1895–1995. Cambridge, England: Cambridge University Press; 1997.
   Google Scholar
• Cawein A, Emini E, Watson M, et al. Human capital gaps in vaccine development: an issue for global vaccine development and global health. Ann N Y Acad Sci. 2017;1395:3–11.
   PubMed Web of Science ®Google Scholar
• Allen A. Vaccine: the controversial story of medicine’s greatest lifesaver. New York, NY: WW Norton & Company; 2007.
   Google Scholar
• Harrison JA. Wrong about vaccine safety: a review of Andrew Wakefield’s “Callous Disregard”. Open Vaccine J. 2013;6:9–25.
   Google Scholar
• Godlee F. The fraud behind the MMR scare. BMJ. 2011;342:d22.
   Google Scholar
• Mnookin S. The panic virus: a true story of medicine, science, and fear. New York, NY: Simon and Schuster; 2011.
   Google Scholar
• McPhillips HA, Davis RL, Marcuse EK, et al. The rotavirus vaccine’s withdrawal and physicians’; trust in vaccine safety mechanisms. Arch Pediatr Adolesc Med. 2001;155(9):1051–1056.
   PubMedGoogle Scholar
• Nigrovic LE, Thompson KM. The Lyme vaccine: a cautionary tale. Epidemiol Infect. 2007;135(1):1–8.
   PubMed Web of Science ®Google Scholar
• Bishop JM. Nobel lecture. Retroviruses and oncogenes II. Biosci Rep. 1990;10(6):473–491.
   PubMed Web of Science ®Google Scholar
• Bryan JT, Buckland B, Hammond J, et al. Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine. Curr Opin Chem Biol. 2016;32:34–47.
   PubMed Web of Science ®Google Scholar
• Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988;61(10):1942–1956.
   PubMed Web of Science ®Google Scholar
• C.f.D. Control, prevention, ten great public health achievements–United States, 1900–1999. MMWR Morbidity Mortality Weekly Report. 1999;48(12):241.
   PubMedGoogle Scholar